Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 4,760 |
| Other current assets | 10 |
| TOTAL | $4,770 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $4,770 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 10 |
| Accrued Expenses | 8 |
| Other current liabilities | 840 |
| TOTAL | $860 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $860 |
| Shareholders' Equity | |
| Retained earnings | -27,110 |
| Other shareholders' equity | -30 |
| TOTAL | $3,900 |
| Total Liabilities And Equity | $4,760 |